Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer

Published:2011-07-13 Issue:4 Volume:30 Page:1548-1556
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Goto Yasushi,Sekine Ikuo,Tanioka Maki,Shibata Takashi,Tanai Chiharu,Asahina Hajime,Nokihara Hiroshi,Yamamoto Noboru,Kunitoh Hideo,Ohe Yuichiro,Kikkawa Hironori,Ohki Emiko,Tamura Tomohide

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://www.springerlink.com/index/pdf/10.1007/s10637-011-9715-4

Reference23 articles.

1. Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Canc 4:505–518

2. Sachdev D, Yee D (2007) Disrupting insulin-like growth factor signaling as a potential cancer therapy. Mol Canc Therapeut 6:1–12

3. Samani AA, Yakar S, LeRoith D, Brodt P (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20–47

4. Favoni RE, de Cupis A, Ravera F, Cantoni C, Pirani P, Ardizzoni A, Noonan D, Biassoni R (1994) Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines. Int J Canc 56:858–866

5. Gualberto A, Karp DD (2009) Development of the monoclonal antibody figitumumab, targeting the insulin-like growth factor-1 receptor, for the treatment of patients with non-small-cell lung cancer. Clin Lung Canc 10:273–280

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis;Frontiers in Immunology;2024-08-01

2. Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer;Current Pharmaceutical Design;2022-07

3. The Efficacy of Long-Term Chinese Herbal Medicine Use on Lung Cancer Survival Time: A Retrospective Two-Center Cohort Study with Propensity Score Matching;Evidence-Based Complementary and Alternative Medicine;2021-08-23

4. Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer;Frontiers in Cell and Developmental Biology;2021-03-22

5. The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives;Cancers;2020-02-05